Prediction of renal impairment in elderly patients with congestive heart failure treated with captopril

Cardiovascular Drugs and Therapy

Volumn 10, Issue 1, 1996, Pages 75-79

  Schwartz, Doron ^b   Kornowski, Ran ^a   Schwartz, Idit F ^b   Dotan, Iris ^b   Weinreb, Baruch ^b   Averbuch, Mordechai ^b   Golan, Yoav ^b   Levo, Yoram ^b   Iaina, Adrian ^b  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b NONE

Author keywords

Captopril test; Congestive heart failure; Plasma renin activity; Renal function

Indexed keywords

CAPTOPRIL; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; RENIN;

AGED; ARTICLE; BLOOD PRESSURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DIAGNOSTIC VALUE; DRUG SAFETY; FEMALE; HEART EJECTION FRACTION; HUMAN; KIDNEY FUNCTION; MALE; NEPHROTOXICITY; ORAL DRUG ADMINISTRATION; PLASMA RENIN ACTIVITY; PREDICTION; PRIORITY JOURNAL;

EID: 0029963957     PISSN: 09203206     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00051133     Document Type: Article

References (22)

1. The Consensus Trial Study Group: Effects of enalapril on mortality in severe congestive heart failure. N Engl J Med 1987;316:1429-1435.
2. The SOLVD investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991;325: 293-302.
3. The SAVE investigators. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 1992;327:669-677.
4. Packer M, Lee WH, Kessler PD, Medina N, Yushak RN, Gottlieb SS. Identification of hyponatremia as a risk factor for the development of functional renal insufficiency during converting enzyme inhibition in congestive heart failure. J Am Coll Cardiol 1987;10:837-844.
5. Packer M, Lee WH, Medina N, Yushac RN, Kessler PD. Functional renal insufficiency during long term therapy with captopril and enalapril in severe chronic heart failure. Ann Intern Med 1987;107:346-357.
6. Packer M, Lee WH, Yushac RN, Medina M. Comparison of captopril and enalapril in patients with severe congestive heart failure. N Engl J Med 1986;315:847-853.
7. Packer M. Why do the kidneys release renin in patients with congestive heart failure? A nephrocentric view of converting enzyme inhibition. Am J Cardiol 1987;60:179-184.
8. Brown JJ, Davies DL, Johnson VW, Lever AF, Robertson JIS. Renin relationships in congestive heart failure, treated and untreated. Am Heart J 1970;80:329-342.
9. Montgomery AJ, Shepherd AN, Emslie-Smith D. Severe hyponatremia and cardiac failure successfully treated with captopril. Br Med J 1982;284:1085-1086.
10. Muller FB, Sealey JE, Case DB, et al. The captopril test for identifying renovascular disease in hypertensive patients. Am J Med 1986;80:633-644.
11. Pallone TL. Vasoconstriction of outer medullary vasa recta by angiotensin II is modulated by prostaglandin E2. Am J Physiol 1994;266:F850-F857.
12. Hansell P. Influence of captopril on red cell velocity in the vasa recta of the renal medulla. Ups J Med Sci 1993;98: 149-158.
13. Pallone TL, Work J, Myers RL, Jamison RL. Transport of sodium and urea in outer medullary descending vasa recta. J Clin Invest 1994;93:212-222.
14. Nicholls MG, Ikram H, Fitzpatrick MA, Crozier IG. Converting enzyme inhibitors in heart failure. Eur Heart J 1988;9(Suppl H):77-83.
15. Suki WM. Renal hemodynamic consequences of angiotensin-converting enzyme inhibition in congestive heart failure. Arch Intern Med 1989;149:669-673.
16. Kastner PR, Hall JE, Guyton AC. Control of glomerular filtration rate: Role of intrarenally formed angiotensin II. Am J Physiol 1984;246:F897-F906.
17. Ichikawa I, Pfeffer JM, Pfeffer MA, Hostetter TH, Brenner BM. Role of angiotensin II in the altered renal function of congestive heart failure. Circ Res 1984;55:669-675.
18. Hall JE. Regulation of renal hemodynamics. In: Guyton AC, Hall JE, eds. Cardiovascular Physiology 4, Vol. 26). Baltimore, MD: University Park Press, 1982;243-321.
19. Mitchell KD, Navar LG. Superficial nephron responses to peritubular capillary infusions of angiotensin I and II. Am J Physiol 1987;238:F818-F824.
20. Rosivall L, Navar LG. Effects on renal hemodynamics of intra-arterial infusion of angiotensin I and II. Am J Physiol 1983;252:F181-F187.
21. Schor N, Ichikawa I, Brenner BM. Glomerular adaptations to chronic dietary salt restriction or excess. Am J Physiol 1980;238;F428-F436.
22. Schwartz D, Averbuch M, Pines A, Kornowski R, Levo Y. Renal toxicity of enalapril in very elderly patients with progressive, severe congestive heart failure. Chest 1991; 100:1558-1561.